Inflammatory bowel disease trials recruiting in New York

All Inflammatory bowel disease trials nationally

Cities in New York

Recruiting trials in New York

• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
  NCT04844606 · Phase: Phase 3 · Ages: 2 Years to 19 Years · Sex: All (male and female) · New York: New York
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: New York
• BOOM-IBD2 Pivotal Clinical Trial
  NCT06571669 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · New York: Manhasset, New York
• Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
  NCT06274554 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York